(French) VIH : des globules blancs très actifs dans l’hyperactivation du système immunitaire

Sorry, this press release is only available in French.

Press release – Inserm press room (French) VIH : des globules blancs très actifs dans l’hyperactivation du système immunitaire Link : https://presse.inserm.fr/en/french-vih-des-globules-blancs-tr-s-actifs-dans-l-hyperactivation-du-syst-me-immunitaire-/1198/

Other contents In the same category :

Immunology, inflammation, infectiology and microbiology Voir tout

Published Now in the New England Journal of Medicine: The Initial Results of the Solidarity/Discovery Clinical Trial

Back at the start of the pandemic, Inserm, through its REACTing consortium, set up Discovery: a European clinical trial to evaluate the efficacy of four antiviral drugs repurposed for the treatment of patients hospitalized with COVID-19 (remdesivir, hydroxychloroquine, lopinavir and interferon beta-1a). ...

COVID-19: Timing Issues Prevent SARS-CoV-2 Host Cells From Stopping Replication

Les cellules cibles du SARS-CoV-2 dans les voies respiratoires produisent des molécules antivirales suite à l’infection, mais trop tardivement pour empêcher la réplication du virus. ...

(French) VIH : des globules blancs très actifs dans l’hyperactivation du système immunitaire

Other contents In the same category :

Published Now in the New England Journal of Medicine: The Initial Results of the Solidarity/Discovery Clinical Trial

COVID-19: Timing Issues Prevent SARS-CoV-2 Host Cells From Stopping Replication

Launch of a European clinical trial against COVID-19

Les vaccins à ARNm susceptibles de modifier notre génome, vraiment ?

New Antibiotics Developed by Inserm and Université de Rennes 1

The BCG vaccine against COVID-19 – really?